Integrated Bioinformatics and Experimental Validation Reveal the Diagnostic and Prognostic Value of SMDT1 in Thyroid Carcinoma
Open Access
- 18 July 2026
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (14) , 2250
Abstract
Background: Thyroid carcinoma (THCA), especially papillary thyroid carcinoma (PTC), remains clinically challenging because recurrence and metastasis occur in a subset of patients. SMDT1 is an essential regulator of the mitochondrial calcium uniporter complex that may influence tumor progression, but its role in thyroid carcinoma is unclear. This study investigated the expression, clinical significance, and biological functions of SMDT1 in thyroid carcinoma. Methods: Public databases were used to analyze SMDT1 expression, diagnostic value, prognostic relevance, co-expression networks, functional enrichment, protein interactions, and immune infiltration. SMDT1 expression was validated in 50 paired PTC and adjacent non-tumorous tissues. In vitro SMDT1 overexpression was performed in PTC cell lines, followed by quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting (WB), CCK-8, colony formation, wound healing, and transwell assays. Results:SMDT1 was significantly downregulated in thyroid carcinoma tissues, PTC tissues, and PTC cell lines. Low SMDT1 expression was associated with lymph node metastasis and shorter disease-free survival. Functional analyses linked SMDT1 with mitochondrial calcium transport, oxidative phosphorylation, apoptosis, cellular senescence, and immune infiltration, including CD8+ T cells and activated NK cells. SMDT1 overexpression significantly suppressed PTC cell proliferation, colony formation, migration, and invasion. Conclusions:SMDT1 may function as a tumor suppressor in thyroid carcinoma and has potential diagnostic and prognostic value. Its effects may involve mitochondrial calcium homeostasis, metabolic regulation, and immune microenvironment remodeling.Keywords
Funding Information
- Clinical Research Center for Precision Management of Thyroid Cancer of Fujian Province (2022Y2006)
This publication has 51 references indexed in Scilit:
- Mitochondrial Regulation of CD8⁺ T Cells: Mechanisms and Therapeutic ModulationAdvanced Science, 2025
- Mitochondrial calcium uniporter complex: Unveiling the interplay between its regulators and calcium homeostasisCellular Signalling, 2024
- Thyroid CancerJAMA, 2024
- SMDT1 variants impair EMRE-mediated mitochondrial calcium uptake in patients with muscle involvementBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancerClinical and Translational Medicine, 2023
- Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondriaCancer Letters, 2023
- Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selectionCellular Oncology, 2023
- Intersection between calcium signalling and epithelial-mesenchymal plasticity in the context of cancerCell Calcium, 2023
- Quantitative analysis of mitochondrial calcium uniporter (MCU) and essential MCU regulator (EMRE) in mitochondria from mouse tissues and HeLa cellsFEBS Open Bio, 2022
- Mechanisms of EMRE-Dependent MCU Opening in the Mitochondrial Calcium Uniporter ComplexCell Reports, 2020